• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺组织蛋白质组学分析在肺动脉高压患者中的应用。

Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension.

机构信息

Centre for Pharmacology and Therapeutics, Department of Medicine, Imperial College London, London, UK.

出版信息

Circulation. 2010 Nov 16;122(20):2058-67. doi: 10.1161/CIRCULATIONAHA.110.972745. Epub 2010 Nov 1.

DOI:10.1161/CIRCULATIONAHA.110.972745
PMID:21041689
Abstract

BACKGROUND

Pulmonary arterial hypertension is a disorder of vascular remodeling causing increased resistance to pulmonary blood flow. The expression of proteins in lungs from pulmonary arterial hypertension patients was investigated in an unbiased approach to further understand the pathobiology of this disease.

METHODS AND RESULTS

Label-free liquid chromatography tandem mass spectrometry was used to compare protein profiles in surgical samples of lungs from 8 patients with pulmonary arterial hypertension and 8 control subjects. More than 300 proteins were detected. On the basis of robust criteria, the levels of 25 proteins varied between the 2 groups. The majority of upregulated proteins were associated with cell growth, proliferation, and cell metabolism. Novel findings included an increased expression of chloride intracellular channel 4, receptor for advanced glycation end products, and periostin. Increased expression of chloride intracellular channel 4, a multifunctional protein involved in angiogenesis, and several signaling pathways implicated in pulmonary arterial hypertension--transforming growth factor-β, vascular endothelial growth factor, and bone morphogenetic protein--was confirmed by Western blotting and localized predominantly to endothelial cells in occlusive and plexiform vascular lesions.

CONCLUSIONS

Label-free proteomics identified differences in the expression of several proteins in the pulmonary arterial hypertension lung, many of which are relevant to the disease process. Increased expression of chloride intracellular channel 4 may be pertinent to the disorganized angiogenesis of plexiform lesions.

摘要

背景

肺动脉高压是一种血管重构紊乱的疾病,导致肺血流阻力增加。本研究采用无偏倚的方法研究肺动脉高压患者肺部的蛋白质表达,以进一步了解该疾病的病理生物学。

方法和结果

采用无标记液相色谱串联质谱法比较了 8 例肺动脉高压患者和 8 例对照手术肺组织的蛋白质谱。检测到 300 多种蛋白质。基于严格的标准,2 组间有 25 种蛋白质的水平存在差异。上调的蛋白质大多数与细胞生长、增殖和细胞代谢有关。新发现包括氯离子通道 4、晚期糖基化终产物受体和骨膜蛋白的表达增加。氯离子通道 4 是一种多功能蛋白,参与血管生成和多个信号通路,如转化生长因子-β、血管内皮生长因子和骨形态发生蛋白,在闭塞性和丛状血管病变中内皮细胞表达增加,这通过 Western 印迹得到了证实。

结论

无标记蛋白质组学鉴定了肺动脉高压肺中几种蛋白质的表达差异,其中许多与疾病过程有关。氯离子通道 4 的表达增加可能与丛状病变中血管生成紊乱有关。

相似文献

1
Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension.肺组织蛋白质组学分析在肺动脉高压患者中的应用。
Circulation. 2010 Nov 16;122(20):2058-67. doi: 10.1161/CIRCULATIONAHA.110.972745. Epub 2010 Nov 1.
2
GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.GDF-15 在肺动脉高压患者的丛状病变中大量表达,并影响肺内皮细胞的增殖和凋亡。
Respir Res. 2011 May 6;12(1):62. doi: 10.1186/1465-9921-12-62.
3
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.原发性肺动脉高压与II型骨形态发生蛋白受体的肺血管表达降低有关。
Circulation. 2002 Apr 9;105(14):1672-8. doi: 10.1161/01.cir.0000012754.72951.3d.
4
NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.NMDA 型谷氨酸受体激活促进血管重塑和肺动脉高压。
Circulation. 2018 May 29;137(22):2371-2389. doi: 10.1161/CIRCULATIONAHA.117.029930. Epub 2018 Feb 14.
5
Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.人类内源性逆转录病毒-K的上调与肺动脉高压中的免疫和炎症相关。
Circulation. 2017 Nov 14;136(20):1920-1935. doi: 10.1161/CIRCULATIONAHA.117.027589. Epub 2017 Sep 21.
6
Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension.桩蛋白调节肺动脉平滑肌细胞在肺动脉高压中的功能。
Am J Pathol. 2012 Nov;181(5):1621-33. doi: 10.1016/j.ajpath.2012.07.026. Epub 2012 Sep 6.
7
Fhl-1, a new key protein in pulmonary hypertension.Fhl-1,一种肺动脉高压中的新关键蛋白。
Circulation. 2008 Sep 9;118(11):1183-94. doi: 10.1161/CIRCULATIONAHA.107.761916. Epub 2008 Aug 25.
8
Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.硬皮病相关肺动脉高压中的抵抗素样分子β
Am J Respir Cell Mol Biol. 2009 Nov;41(5):553-61. doi: 10.1165/rcmb.2008-0271OC. Epub 2009 Feb 27.
9
Subcellular distribution patterns and elevated expression of GNA11 and GNA14 proteins in the lungs of humans with pulmonary arterial hypertension.肺动脉高压患者肺组织中GNA11和GNA14蛋白的亚细胞分布模式及表达上调
Cell Biol Int. 2014 Sep;38(9):1041-9. doi: 10.1002/cbin.10292. Epub 2014 May 19.
10
Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in pulmonary hypertensive rats.肺压降低可减弱肺高压大鼠肺蛋白质组学分析鉴定的蛋白表达。
Proteomics. 2011 Dec;11(23):4492-502. doi: 10.1002/pmic.201100171. Epub 2011 Oct 28.

引用本文的文献

1
Comprehensive proteomic characterization of pulmonary arterial hypertension in Chinese people.中国人肺动脉高压的综合蛋白质组学特征分析
Front Mol Biosci. 2025 Aug 14;12:1652083. doi: 10.3389/fmolb.2025.1652083. eCollection 2025.
2
Critical role of mitochondrial dynamics in chronic respiratory diseases and new therapeutic directions.线粒体动力学在慢性呼吸道疾病中的关键作用及新的治疗方向
Chin Med J (Engl). 2025 Aug 5;138(15):1783-1793. doi: 10.1097/CM9.0000000000003704. Epub 2025 Jul 10.
3
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.
系统性硬化症中肺动脉高压的多模式筛查:当前方法与未来方向
Medicina (Kaunas). 2024 Dec 27;61(1):19. doi: 10.3390/medicina61010019.
4
Carotid Baroreceptor Stimulation Ameliorates Pulmonary Arterial Remodeling in Rats With Hypoxia-Induced Pulmonary Hypertension.颈动脉压力感受器刺激可改善缺氧性肺动脉高压大鼠的肺血管重构。
J Am Heart Assoc. 2024 Oct;13(19):e035868. doi: 10.1161/JAHA.124.035868. Epub 2024 Sep 30.
5
Mechanisms and treatment of pulmonary arterial hypertension.肺动脉高压的发病机制与治疗
Nat Rev Cardiol. 2025 Feb;22(2):105-120. doi: 10.1038/s41569-024-01064-4. Epub 2024 Aug 7.
6
[Research progress on bioinformatics in pulmonary arterial hypertension].[肺动脉高压的生物信息学研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):425-431. doi: 10.7499/j.issn.1008-8830.2310076.
7
Endothelial periostin regulates vascular remodeling by promoting endothelial dysfunction in pulmonary arterial hypertension.内皮细胞骨膜蛋白通过促进肺动脉高压中的内皮功能障碍来调节血管重塑。
Anim Cells Syst (Seoul). 2024 Jan 3;28(1):1-14. doi: 10.1080/19768354.2023.2300437. eCollection 2024.
8
Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.变性二尖瓣疾病继发肺动脉高压犬的肺动、静脉及肺组织蛋白质组学分析。
PLoS One. 2024 Jan 5;19(1):e0296068. doi: 10.1371/journal.pone.0296068. eCollection 2024.
9
Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives.肺动脉高压的风险分层:更新与展望
J Clin Med. 2023 Jun 28;12(13):4349. doi: 10.3390/jcm12134349.
10
Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.定量蛋白质组学和磷酸化蛋白质组学分析肺动脉高压大鼠模型肺组织。
Int J Mol Sci. 2023 Jun 1;24(11):9629. doi: 10.3390/ijms24119629.